Raising the volume on real-world data and analytics
Real Talk on Real-World Evidence: Practical Applications in 2021
Leaders from Advisory Board Research and Optum Life Sciences discuss how the next wave of real-world evidence (RWE) use cases can help address health disparities, improve trial designs and demonstrate the value of innovative therapies.
Is your real-world data research ready?
Real-world data (RWD) helps life sciences researchers and business leaders assess how products are performing. But before investing in RWD, it’s important to evaluate how accurately it reflects the patient experience. See our four questions for evaluating data.
Integrated data helps capture patient experiences
Integrated data can help us realize greater efficiency in understanding what’s really happening with patients as they navigate the health care system. Lou Brooks, vice president of Commercial Analytics, discusses how integrated data is ushering in the future of health care analytics.
Clinicogenomics: Next leap in real-world data
Optum is working to combine claims and EHR data with genomics data to generate new insights into disease and drug performance. Dr. Brian Solow, chief medical officer, Optum® Life Sciences and Dr. Jill Hagenkord, chief medical officer, Optum® Clinical Genomics, share key strategies for taking this bold leap.
How COVID-19 could reshape clinical trials (Part I)
Estimates suggest more than 1,300 clinical trials have been negatively impacted by COVID-19. Peter Payne and Cynthia Senerchia of the Optum® Digital Research Network share how the pandemic has created new urgency for disruption and digitization of clinical trials in this Advisory Board Q&A.
What does clinical innovation look like in the future? (Part II)
The second part of our Q&A series on the clinical trial landscape features interviews with Optum® Digital Research Network experts. Peter Payne and Cynthia Senerchia return to share how innovation will impact the future of clinical trials and evidence generation.
RWD informs rare disease insights
The robust, end-to-end patient view provided by real-world data (RWD) fills the data divide of rare and genetic diseases. Learn how researchers can use RWD to decipher the history and clinical manifestations of rare and genetic diseases to power treatment development.
Machine Learning: How Life Sciences Companies are Using AI to Help Control Diabetes
What if we could improve and speed up the way scientists analyze and process data? What if AI could help us develop better predictive models for chronic disease? Experts share their real-world experiences doing just that in this on-demand webinar.
Whole Patient Data: What It Means & Why It Helps in Cancer Research
During this on-demand webinar, Optum subject matter experts discuss how extracting and enriching EHR data across care settings adds meaningful insight into the factors that may affect patient outcomes.
Explore the Optum Digital Research Network
The clinical trial paradigm is ripe for disruption. Everyone knows the challenges, the cost overruns, the deadlines missed, and the enormous risks in finding patients. See how the Optum Digital Research Network is changing the future of clinical trial processes.
FDA guidance on RWE signals new opportunities
With the FDA mandating the use of real-world evidence to support regulatory decision-making, there’s never been a better time for life sciences companies to invest in an enterprise-wide data strategy. Learn how Optum can help you develop greater data applications.
The great data transition: making the move from claims to EHR data
As talk of pandemics and population health trends fill our days, this white paper walks you through the ways claims data answers the hows, while EHR data gets to the whys. Learn how the immediacy of EHR data availability can be significantly impactful, particularly as the health care system works to address COVID-19.